2 weeks Biogen Hammered As Lackluster Guidance Drags On Fourth-Quarter Beat Investor's Business Daily

Biogen stock took a hit Wednesday after the biotech company issued light guidance for 2025 despite beating most fourth-quarter expectations.
The post Biogen Hammered As Lackluster Guidance Drags On Fourth-Quarter Beat appeared first on Investor's …